Abstract

Hypertension is highly prevalent and frequently uncontrolled in hemodialysis (HD) patients 1, and meta-analyses of randomized controlled trials show that the treatment of HD patients with antihypertensive medications is associated with improved cardiovascular outcomes 2,3 which remain a leading cause of death in HD patients 4. Nonetheless, there is no consensus on whether to lower elevated blood pressure (BP) among HD patients and to what level should BP be targeted 5,6. This is in large part due to difficulties associated with accurate assessment of BP among HD patients 7–10.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.